Spero Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SPRO and other ETFs, options, and stocks.

About SPRO

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. The company was founded by Ankit A. 

CEO
Satyavrat Shukla
CEOSatyavrat Shukla
Employees
46
Employees46
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2013
Founded2013
Employees
46
Employees46

SPRO Key Statistics

Market cap
75.99M
Market cap75.99M
Price-Earnings ratio
3.33
Price-Earnings ratio3.33
Dividend yield
—
Dividend yield—
Average volume
222.60K
Average volume222.60K
High today
$1.45
High today$1.45
Low today
$1.41
Low today$1.41
Open price
$1.42
Open price$1.42
Volume
110.04K
Volume110.04K
52 Week high
$2.00
52 Week high$2.00
52 Week low
$0.99
52 Week low$0.99
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.